/
| GEL thousands | 2020¹ | 2021² | 2022³ | 2023 | 2024 |
|---|---|---|---|---|---|
| P&L Items | |||||
| Revenue | Register | Register | 45,245 | Register | Register |
| Adj. Operating Profit⁴ | Register | Register | (5,151) | Register | Register |
| Adj. EBITDA⁴ | Register | Register | 1,801 | Register | Register |
| Net Income | Register | Register | (4,006) | Register | Register |
| Margins & Profitability Ratios (%) | |||||
| Adj. Operating Profit Margin⁴ | Register | Register | -11.4% | Register | Register |
| Adj. EBITDA Margin⁴ | Register | Register | 4.0% | Register | Register |
| Net Income Margin | Register | Register | -8.9% | Register | Register |
| Balance Sheet Items & Leverage | |||||
| Total Assets | Register | Register | 37,344 | Register | Register |
| Total Debt⁵ | Register | Register | 25,266 | Register | Register |
| Total Debt⁵ / Adj. EBITDA⁴ | Register | Register | 14.03x | Register | Register |
| Total Equity | Register | Register | 1,036 | Register | Register |
| ROAE | Register | Register | -311.6% | Register | Register |
¹ Pre-opening year: revenue is consulting income.
² The hospital opened in October 2021; revenue includes GEL 4.2m (USD 1.31m) of design and engineering services income.
³ Revenue includes GEL 6.0m (USD 2.04m) of management, design and engineering services income outside the hospital business; the auditor could not confirm it is revenue rather than a loan or capital contribution.
⁴ Adj. Operating Profit has been adjusted to exclude non-recurring and one-time items. Adj. EBITDA is calculated by adding back D&A expenses to the adjusted operating profit.
⁵ Total debt includes lease liabilities, where applicable.